Signify Health, Inc. (NYSE:SGFY) insider Steve Senneff acquired 2,500 shares of the company’s stock in a transaction dated Monday, November 22nd. The shares were acquired at an average cost of $13.27 per share, with a total value of $33,175.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Steve Senneff also recently made the following trade(s):
- On Tuesday, November 16th, Steve Senneff acquired 10,000 shares of Signify Health stock. The shares were acquired at an average cost of $15.32 per share, with a total value of $153,200.00.
Shares of SGFY opened at $13.91 on Thursday. The company’s fifty day moving average is $18.40 and its two-hundred day moving average is $24.12. Signify Health, Inc. has a fifty-two week low of $13.07 and a fifty-two week high of $40.79. The company has a current ratio of 5.55, a quick ratio of 5.90 and a debt-to-equity ratio of 0.23.
A number of research analysts have recently weighed in on SGFY shares. Barclays raised shares of Signify Health from an “equal weight” rating to an “overweight” rating and set a $30.00 price objective for the company in a research note on Thursday, August 12th. Zacks Investment Research cut shares of Signify Health from a “hold” rating to a “sell” rating in a research note on Friday, November 12th. Robert W. Baird cut shares of Signify Health from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $30.00 to $24.00 in a research note on Thursday, September 23rd. Cowen assumed coverage on shares of Signify Health in a research note on Thursday, September 9th. They issued a “market perform” rating and a $27.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Signify Health from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Monday, November 15th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Signify Health has an average rating of “Hold” and an average target price of $31.22.
Institutional investors and hedge funds have recently made changes to their positions in the business. Citigroup Inc. acquired a new position in shares of Signify Health in the 1st quarter valued at $59,000. Deutsche Bank AG lifted its holdings in shares of Signify Health by 817.0% during the 2nd quarter. Deutsche Bank AG now owns 2,375 shares of the company’s stock valued at $72,000 after acquiring an additional 2,116 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Signify Health by 35.6% during the 2nd quarter. Wells Fargo & Company MN now owns 3,204 shares of the company’s stock valued at $98,000 after acquiring an additional 841 shares in the last quarter. First Mercantile Trust Co. acquired a new position in shares of Signify Health during the 2nd quarter valued at $127,000. Finally, Key Financial Inc acquired a new position in shares of Signify Health during the 3rd quarter valued at $78,000.
Signify Health Company Profile
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
Featured Story: Treasury Bonds
Receive News & Ratings for Signify Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Signify Health and related companies with MarketBeat.com's FREE daily email newsletter.